MSD Partners’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

MSD Partners’s Portfolio NBRV Stock Details NBRV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$27K	–	44
2020 Q3	$27K	Hold	200	–	–	0.01%	34
2020 Q2	$34K	Hold	200	–	–	0.01%	27
2020 Q1	$29K	Hold	200	–	–	0.01%	26
2019 Q4	$66K	Hold	200	–	–	0.01%	18
2019 Q3	$100K	Hold	200	–	–	0.01%	27
2019 Q2	$122K	Hold	200	–	–	0.01%	26
2019 Q1	$122K	Hold	200	–	–	0.02%	25
2018 Q4	$73K	Hold	200	–	–	0.01%	26
2018 Q3	$135K	Hold	200	–	–	0.01%	35
2018 Q2	$174K	Hold	200	–	–	0.01%	39
2018 Q1	$252K	Hold	200	–	–	0.01%	31
2017 Q4	$299K	Hold	200	–	–	0.02%	22
2017 Q3	$410K	Buy	+200	New	+$469K	0.01%	32

Other funds holding NBRV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

AICPI

ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

MSD Partners's NBRV Position: Q4 2020 in Review

MSD Partners sold out of Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) in Q4 2020, closing a stake of 200 shares — an estimated $27K sold.

MSD Partners first reported a position in NBRV in Q3 2017 and held it in 13 quarters. The position peaked at $410K in Q3 2017. 33 funds tracked by Wall St. Rank hold NBRV as of Q4 2020.

MSD Partners reported no remaining Nabriva Therapeutics plc Ordinary Shares Ireland position as of Q4 2020 after selling out during the quarter.
MSD Partners sold 200 Nabriva Therapeutics plc Ordinary Shares Ireland shares in Q4 2020, an estimated $27K.
MSD Partners first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2017 and held it in 13 quarters.
MSD Partners's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $410K in Q3 2017.
33 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2020.

Based on MSD Partners's 13F filing for Q4 2020, filed 16 Feb 2021.